Lecithin-cholesterol acyltransferase deficiency with the finding of "zebra bodies": A diagnostic challenge in the context of suspected Fabry disease.

Lecithin-Cholesterol Acyltransferase Deficiency as a Rare Cause of Bilateral Corneal Opacities: A Case Report of a Novel Frameshift Mutation.

Quantitative Assessment of Visual Function in Japanese Patients With Lecithin-Cholesterol Acyltransferase Gene Abnormalities: A Case-Control Study.

Loss of LCAT function aggravates metabolic-associated steatohepatitis (MASH) in golden Syrian hamster.

IgG3κ Monoclonal Membranous Nephropathy Associated With Acquired Lecithin Cholesterol Acyltransferase Deficiency.

A Case of Acquired LCAT Deficiency with the Discrepancy between Spontaneous Resolution of Proteinuria and Continually Low HDL Cholesterol Levels.

Short-Term Treatment for Immune-Mediated Acquired Lecithin-Cholesterol Acyltransferase Deficiency Restores the High-Density Lipoprotein Function: A Case Report.

Lipoprotein X - Pathophysiology, diagnosis, and management.

LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidation.

Novel pathogenic variant in the LCAT gene in a compound heterozygous patient with fish-eye disease and a mild phenotype.

Gliflozins, sucrose and flavonoids are allosteric activators of lecithin-cholesterol acyltransferase.

A Novel Symptomatic Lecithin-Cholesterol Acyltransferase Gene Mutation With Corneal Amyloidosis.

Rescue of Familial Lecithin:Cholesterol Acyltranferase Deficiency Mutations with an Allosteric Activator.

Unveiling Renal Lipid Deposition: A Rare Case of Hepatic Glomerulosclerosis Resembling Lecithin-Cholesterol Acyltransferase (LCAT) Deficiency Post Liver Transplantation.

A novel splicing variant in ABCA1 in the first reported Hong Kong Chinese patient with high-density lipoprotein deficiency.

Longitudinal analysis of clinical and laboratory biomarkers in a patient with familial lecithin: cholesterol acyltransferase deficiency (FLD) and accelerated eGFR decline: A case study.

Estrogen Induces LCAT to Maintain Cholesterol Homeostasis and Suppress Hepatocellular Carcinoma Development.

Familial LCAT Deficiency and Low HDL-C Levels: In silico Characterization of Two Rare LCAT Missense Mutations.

A High-Throughput NMR Method for Lipoprotein-X Quantification.

Abnormal Lipoproteins Trigger Oxidative Stress-Mediated Apoptosis of Renal Cells in LCAT Deficiency.

HDL and chronic kidney disease.

Very low HDL levels: clinical assessment and management.

Two novel variants in the lecithin:cholesterol acyltransferase gene resulted in classic LCAT deficiency.

A rare case of nephrotic syndrome and Tangier disease.

Novel therapeutic opportunities for familial lecithin:cholesterol acyltransferase deficiency: promises and challenges.

Rapidly progressive renal failure to reveal LCAT deficiency in an Algerian family.

First-in-human autologous implantation of genetically modified adipocytes expressing LCAT for the treatment of familial LCAT deficiency.

Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study.

A rare case of renal involvement in Lecithin-Cholesterol Acyltransferase (LCAT) deficiency: lessons for the clinical nephrologist.

A Simple Fluorescent Cholesterol Labeling Method to Cryoprotect and Detect Plasma Lipoprotein-X.

LCAT-trial-24 weeks: Protocol for a clinical study to evaluate the safety of regenerative medicine and gene therapy by the autologous transplantation of human lecithin:cholesterol acyltransferase gene-transduced human pre-adipocytes.

Plasma FA composition in familial LCAT deficiency indicates SOAT2-derived cholesteryl ester formation in humans.

Familial lecithin-cholesterol acyltransferase deficiency: If so rare, why so frequent in the state of Piauí, northeastern Brazil?

Clinical Dilemma of Corneal Opacity, Very Low High-density Lipoprotein, and Nephrotic Syndrome: Mystery Revealed.

LCAT- targeted therapies: Progress, failures and future.

A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency.

A novel pathogenic variant in LCAT causing FLD. A case report.

The HDL mimetic CER-001 remodels plasma lipoproteins and reduces kidney lipid deposits in inherited lecithin:cholesterol acyltransferase deficiency.

LCAT deficiency and pregnancy: Case report.

LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred.

Using Literature Based Discovery to Gain Insights Into the Metabolomic Processes of Cardiac Arrest.

Current Status of Familial LCAT Deficiency in Japan.

High-Density Lipoproteins and the Kidney.

rHDL modeling and the anchoring mechanism of LCAT activation.

CER-001 ameliorates lipid profile and kidney disease in a mouse model of familial LCAT deficiency.

Progression of chronic kidney disease in familial LCAT deficiency: a follow-up of the Italian cohort.

Spontaneous Atherosclerosis in Aged LCAT-Deficient Hamsters With Enhanced Oxidative Stress-Brief Report.

Activation of Naturally Occurring Lecithin:Cholesterol Acyltransferase Mutants by a Novel Activator Compound.

Genetic, biochemical, and clinical features of LCAT deficiency: update for 2020.

Esterification of 4β-hydroxycholesterol and other oxysterols in human plasma occurs independently of LCAT.

Familial LCAT deficiency and cardiovascular disease: the game is not over. A case of dramatic multivessel atherosclerosis.

Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings.

Novel lecithin: cholesterol acyltransferase-based therapeutic approaches.

LCAT protects against Lipoprotein-X formation in a murine model of drug-induced intrahepatic cholestasis.

Lipid Profile Rather Than the LCAT Mutation Explains Renal Disease in Familial LCAT Deficiency.

Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.

The P274S Mutation of Lecithin-Cholesterol Acyltransferase (LCAT) and Its Clinical Manifestations in a Large Kindred.

Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo.

Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice.

Case Report: Management of Corneal Clouding from Lecithin: Cholesterol Acyltransferase Deficiency.

LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.

[Glomerulopathy associated with lecithin-cholesterol-acyltransferase deficiency: A case report and literature review].

A proteomic approach to identify novel disease biomarkers in LCAT deficiency.

Finding a very rare mutation in non-Caucasian LCAT patients from Southwest Asia for the first time.

Lipoprotein-X fifty years after its original discovery.

Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.

Ocular and Genetic Characteristics Observed in Two Cases of Fish-Eye Disease.

Paradoxical fall in proteinuria during pregnancy in an LCAT-deficient patient-A case report.

Lp8 is potentially associated with partial lecithin:cholesterol acyltransferase deficiency in a patient with primary biliary cirrhosis.

Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: A case report and literature review.

Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.

LCAT deficiency as a cause of proteinuria and corneal opacification.

Loss of LCAT activity in the golden Syrian hamster elicits pro-atherogenic dyslipidemia and enhanced atherosclerosis.

Novel metabolic phenotypes in lecithin cholesterol acyltyransferase-deficient mice.

Novel Missense LCAT Gene Mutation Associated with an Atypical Phenotype of Familial LCAT Deficiency in Two Portuguese Brothers.

A novel homozygous mutation causing lecithin-cholesterol acyltransferase deficiency in a proband of Romanian origin with a record of extreme gestational hyperlipidemia.

Development of a novel fluorescent activity assay for lecithin:cholesterol acyltransferase.

AJKD Atlas of Renal Pathology: Lecithin-Cholesterol Acyltransferase (LCAT) Deficiency.

A case of acquired lecithin:cholesterol acyltransferase deficiency with sarcoidosis that remitted spontaneously.

Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency.

[Lecithin:Cholesterol Acyltransferase Deficiency, from genes to therapy].

Familial Lecithin Cholesterol Acyl Transferase Deficiency with Chronic Kidney Disease.

Sequential kidney-liver transplantation from the same living donor for lecithin cholesterol acyl transferase deficiency.

ApoA-IMilano phospholipid complex (ETC-216) infusion in human volunteers. Insights into the phenotypic characteristics of ApoA-IMilano carriers.

[Gene-manipulated Adipocytes for the Treatment of Various Intractable Diseases].

Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement.

Lipoprotein X Causes Renal Disease in LCAT Deficiency.

An unusual presentation of LCAT deficiency as nephrotic syndrome with normal serum HDL-C level.

Co-existence of classic familial lecithin-cholesterol acyl transferase deficiency and fish eye disease in the same family.

Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.

Role of LCAT in Atherosclerosis.

Histiocytic and Nonhistiocytic Glomerular Lesions: Foam Cells and Their Mimickers.

Lecithin:Cholesterol Acyltransferase (LCAT) Deficiency Promotes Differentiation of Satellite Cells to Brown Adipocytes in a Cholesterol-dependent Manner.

Beta2-adrenergic activity modulates vascular tone regulation in lecithin:cholesterol acyltransferase knockout mice.

Lack of LCAT reduces the LPS-neutralizing capacity of HDL and enhances LPS-induced inflammation in mice.

Structure and function of lysosomal phospholipase A2 and lecithin:cholesterol acyltransferase.

Familial lecithin-cholesterol acyltransferase (LCAT) deficiency; a differential of proteinuria.

A robust all-atom model for LCAT generated by homology modeling.